Post-modern pathogens: Surprising activities of translocated effectors from E. coli and Legionella

Current Opinion in Microbiology

Volumn 23, Issue , 2015, Pages 73-79

  Pearson, Jaclyn S ^a   Zhang, Ying ^a   Newton, Hayley J ^a   Hartland, Elizabeth L ^a  

^a PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ARGININE; CYSTEINE; CYTOKINE; PHOSPHORYLCHOLINE; PROTEIN; PROTEIN ANKX; PROTEIN ROMA; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL PROTEIN;

ACYLATION; APOPTOSIS; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; CELL FUNCTION; CELL STRUCTURE; CELL SURVIVAL; CELL VACUOLE; COLON MUCOSA; ENTEROPATHOGENIC ESCHERICHIA COLI; HISTONE METHYLATION; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; INFLAMMATION; INTESTINE MUCOSA; LEGIONELLA PNEUMOPHILA; MACROPHAGE; METHYLATION; NECROPTOSIS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PATHOGENESIS; REVIEW; TYPE III SECRETION SYSTEM; TYPE VI SECRETION SYSTEM; ANIMAL; BACTERIAL SECRETION SYSTEM; DRUG EFFECTS; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PROTEIN TRANSPORT;

LEGIONELLA;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; CELL PHYSIOLOGICAL PHENOMENA; ESCHERICHIA COLI; HOST-PATHOGEN INTERACTIONS; HUMANS; LEGIONELLA PNEUMOPHILA; PROTEIN TRANSPORT; VIRULENCE FACTORS;

EID: 84911912871     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2014.11.005     Document Type: Review

References (59)

1. Salomon D., Orth K. Lost after translation: post-translational modifications by bacterial type III effectors. Curr Opin Microbiol 2013, 16:213-220.
2. Bulgin R., Raymond B., Garnett J.A., Frankel G., Crepin V.F., Berger C.N., Arbeloa A. Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors. Infect Immun 2010, 78:1417-1425.
3. Arbibe L., Kim D.W., Batsche E., Pedron T., Mateescu B., Muchardt C., Parsot C., Sansonetti P.J. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 2007, 8:47-56.
4. Li H., Xu H., Zhou Y., Zhang J., Long C., Li S., Chen S., Zhou J.M., Shao F. The phosphothreonine lyase activity of a bacterial type III effector family. Science 2007, 315:1000-1003.
5. Hernandez L.D., Hueffer K., Wenk M.R., Galan J.E. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 2004, 304:1805-1807.
6. Niebuhr K., Giuriato S., Pedron T., Philpott D.J., Gaits F., Sable J., Sheetz M.P., Parsot C., Sansonetti P.J., Payrastre B. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J 2002, 21:5069-5078.
7. Pearson J.S., Riedmaier P., Marches O., Frankel G., Hartland E.L. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-kappaB for degradation. Mol Microbiol 2011, 80:219-230.
8. Muhlen S., Ruchaud-Sparagano M.H., Kenny B. Proteasome-independent degradation of canonical NFkappaB complex components by the NleC protein of pathogenic Escherichia coli. J Biol Chem 2011, 286:5100-5107.
9. Yen H., Ooka T., Iguchi A., Hayashi T., Sugimoto N., Tobe T. NleC, a type III secretion protease, compromises NF-kappaB activation by targeting p65/RelA. PLoS Pathog 2010, 6:e1001231.
10. Baruch K., Gur-Arie L., Nadler C., Koby S., Yerushalmi G., Ben-Neriah Y., Yogev O., Shaulian E., Guttman C., Zarivach R., et al. Metalloprotease type III effectors that specifically cleave JNK and NF-kappaB. EMBO J 2011, 30:221-231.
11. Shao F., Dixon J.E. YopT is a cysteine protease cleaving Rho family GTPases. Adv Exp Med Biol 2003, 529:79-84.
12. Kodama T., Rokuda M., Park K.S., Cantarelli V.V., Matsuda S., Iida T., Honda T. Identification and characterization of VopT, a novel ADP-ribosyltransferase effector protein secreted via the Vibrio parahaemolyticus type III secretion system 2. Cell Microbiol 2007, 9:2598-2609.
13. Engel J., Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 2009, 12:61-66.
14. Hubber A., Kubori T., Nagai H. Modulation of the ubiquitination machinery by Legionella. Curr Top Microbiol Immunol 2013, 376:227-247.
15. Cui J., Shao F. Biochemistry and cell signaling taught by bacterial effectors. Trends Biochem Sci 2011, 36:532-540.
16. Hsu F., Luo X., Qiu J., Teng Y.B., Jin J., Smolka M.B., Luo Z.Q., Mao Y. The Legionella effector SidC defines a unique family of ubiquitin ligases important for bacterial phagosomal remodeling. Proc Natl Acad Sci USA 2014, 111:10538-10543.
17. Wu B., Skarina T., Yee A., Jobin M.C., Dileo R., Semesi A., Fares C., Lemak A., Coombes B.K., Arrowsmith C.H., et al. NleG Type 3 effectors from enterohaemorrhagic Escherichia coli are U-Box E3 ubiquitin ligases. PLoS Pathog 2010, 6:e1000960.
18. Yarbrough M.L., Orth K. AMPylation is a new post-translational modiFICation. Nat Chem Biol 2009, 5:378-379.
19. Wong A.R., Pearson J.S., Bright M.D., Munera D., Robinson K.S., Lee S.F., Frankel G., Hartland E.L. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol 2011, 80:1420-1438.
20. Hauf N., Chakraborty T. Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J Immunol 2003, 170:2074-2082.
21. Ruchaud-Sparagano M.H., Maresca M., Kenny B. Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell Microbiol 2007, 9:1909-1921.
22. Nadler C., Baruch K., Kobi S., Mills E., Haviv G., Farago M., Alkalay I., Bartfeld S., Meyer T.F., Ben-Neriah Y., et al. The Type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog 2010, 6:e1000743.
23. Newton H.J., Pearson J.S., Badea L., Kelly M., Lucas M., Holloway G., Wagstaff K.M., Dunstone M.A., Sloan J., Whisstock J.C., et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog 2010, 6:e1000898.
24. Vossenkamper A., Marches O., Fairclough P.D., Warnes G., Stagg A.J., Lindsay J.O., Evans P.C., Luong le A., Croft N.M., Naik S., et al. Inhibition of NF-kappaB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE. J Immunol 2010, 185:4118-4127.
25. Zhang L., Ding X., Cui J., Xu H., Chen J., Gong Y.N., Hu L., Zhou Y., Ge J., Lu Q., et al. Cysteine methylation disrupts ubiquitin-chain sensing in NF-kappaB activation. Nature 2012, 481:204-208.
26. Clark K., Nanda S., Cohen P. Molecular control of the NEMO family of ubiquitin-binding proteins. Nat Rev Mol Cell Biol 2013, 14:673-685.
27. Wickham M.E., Lupp C., Vazquez A., Mascarenhas M., Coburn B., Coombes B.K., Karmali M.A., Puente J.L., Deng W., Brett Finlay B. Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE. Microbes Infect 2007, 9:400-407.
28. Kelly M., Hart E., Mundy R., Marches O., Wiles S., Badea L., Luck S., Tauschek M., Frankel G., Robins-Browne R.M., et al. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun 2006, 74:2328-2337.
29. Gao X., Wang X., Pham T.H., Feuerbacher L.A., Lubos M.L., Huang M., Olsen R., Mushegian A., Slawson C., Hardwidge P.R. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-kappaB activation. Cell Host Microbe 2013, 13:87-99.
30. Li S., Zhang L., Yao Q., Li L., Dong N., Rong J., Gao W., Ding X., Sun L., Chen X., et al. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 2013, 501:242-246.
31. Pearson J.S., Giogha C., Ong S.Y., Kennedy C.L., Kelly M., Robinson K.S., Lung T.W., Mansell A., Riedmaier P., Oates C.V., et al. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 2013, 501:247-251.
32. Kujat Choy S.L., Boyle E.C., Gal-Mor O., Goode D.L., Valdez Y., Vallance B.A., Finlay B.B. SseK1 and SseK2 are novel translocated proteins of Salmonella enterica serovar typhimurium. Infect Immun 2004, 72:5115-5125.
33. Brown N.F., Coombes B.K., Bishop J.L., Wickham M.E., Lowden M.J., Gal-Mor O., Goode D.L., Boyle E.C., Sanderson K.L., Finlay B.B. Salmonella phage ST64B encodes a member of the SseK/NleB effector family. PLoS One 2011, 6:e17824.
34. Breton C., Imberty A. Structure/function studies of glycosyltransferases. Curr Opin Struct Biol 1999, 9:563-571.
35. Scott F.L., Stec B., Pop C., Dobaczewska M.K., Lee J.J., Monosov E., Robinson H., Salvesen G.S., Schwarzenbacher R., Riedl S.J. The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature 2009, 457:1019-1022.
36. Wang L., Yang J.K., Kabaleeswaran V., Rice A.J., Cruz A.C., Park A.Y., Yin Q., Damko E., Jang S.B., Raunser S., et al. The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat Struct Mol Biol 2010, 17:1324-1329.
37. Imtiyaz H.Z., Zhang Y., Zhang J. Structural requirements for signal-induced target binding of FADD determined by functional reconstitution of FADD deficiency. J Biol Chem 2005, 280:31360-31367.
38. Imtiyaz H.Z., Zhou X., Zhang H., Chen D., Hu T., Zhang J. The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation. J Biol Chem 2009, 284:9917-9926.
39. Newton H.J., Ang D.K., van Driel I.R., Hartland E.L. Molecular pathogenesis of infections caused by Legionella pneumophila. Clin Microbiol Rev 2010, 23:274-298.
40. Kagan J.C., Murata T., Roy C.R. Analysis of Rab1 recruitment to vacuoles containing Legionella pneumophila. Methods Enzymol 2005, 403:71-81.
41. Kagan J.C., Stein M.P., Pypaert M., Roy C.R. Legionella subvert the functions of Rab1 and Sec22b to create a replicative organelle. J Exp Med 2004, 199:1201-1211.
42. Murata T., Delprato A., Ingmundson A., Toomre D.K., Lambright D.G., Roy C.R. The Legionella pneumophila effector protein DrrA is a Rab1 guanine nucleotide-exchange factor. Nat Cell Biol 2006, 8:971-977.
43. Muller M.P., Peters H., Blumer J., Blankenfeldt W., Goody R.S., Itzen A. The Legionella effector protein DrrA AMPylates the membrane traffic regulator Rab1b. Science 2010, 329:946-949.
44. Mukherjee S., Liu X., Arasaki K., McDonough J., Galan J.E., Roy C.R. Modulation of Rab GTPase function by a protein phosphocholine transferase. Nature 2011, 477:103-106.
45. Tan Y., Arnold R.J., Luo Z.Q. Legionella pneumophila regulates the small GTPase Rab1 activity by reversible phosphorylcholination. Proc Natl Acad Sci USA 2011, 108:21212-21217.
46. Pan X., Luhrmann A., Satoh A., Laskowski-Arce M.A., Roy C.R. Ankyrin repeat proteins comprise a diverse family of bacterial type IV effectors. Science 2008, 320:1651-1654.
47. Yarbrough M.L., Li Y., Kinch L.N., Grishin N.V., Ball H.L., Orth K. AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science 2009, 323:269-272.
48. Kinch L.N., Yarbrough M.L., Orth K., Grishin N.V. Fido, a novel AMPylation domain common to fic, doc, and AvrB. PLoS One 2009, 4:e5818.
49. Worby C.A., Mattoo S., Kruger R.P., Corbeil L.B., Koller A., Mendez J.C., Zekarias B., Lazar C., Dixon J.E. The fic domain: regulation of cell signaling by adenylylation. Mol Cell 2009, 34:93-103.
50. Feng F., Yang F., Rong W., Wu X., Zhang J., Chen S., He C., Zhou J.M. A Xanthomonas uridine 5'-monophosphate transferase inhibits plant immune kinases. Nature 2012, 485:114-118.
51. Campanacci V., Mukherjee S., Roy C.R., Cherfils J. Structure of the Legionella effector AnkX reveals the mechanism of phosphocholine transfer by the FIC domain. EMBO J 2013, 32:1469-1477.
52. Tan Y., Luo Z.Q. Legionella pneumophila SidD is a deAMPylase that modifies Rab1. Nature 2011, 475:506-509.
53. Horenkamp F.A., Mukherjee S., Alix E., Schauder C.M., Hubber A.M., Roy C.R., Reinisch K.M. Legionella pneumophila subversion of host vesicular transport by SidC effector proteins. Traffic 2014, 15:488-499.
54. Hardiman C.A., McDonough J.A., Newton H.J., Roy C.R. The role of Rab GTPases in the transport of vacuoles containing Legionella pneumophila and Coxiella burnetii. Biochem Soc Trans 2012, 40:1353-1359.
55. Habyarimana F., Al-Khodor S., Kalia A., Graham J.E., Price C.T., Garcia M.T., Kwaik Y.A. Role for the Ankyrin eukaryotic-like genes of Legionella pneumophila in parasitism of protozoan hosts and human macrophages. Environ Microbiol 2008, 10:1460-1474.
56. Bruggemann H., Cazalet C., Buchrieser C. Adaptation of Legionella pneumophila to the host environment: role of protein secretion, effectors and eukaryotic-like proteins. Curr Opin Microbiol 2006, 9:86-94.
57. de Felipe K.S., Glover R.T., Charpentier X., Anderson O.R., Reyes M., Pericone C.D., Shuman H.A. Legionella eukaryotic-like type IV substrates interfere with organelle trafficking. PLoS Pathog 2008, 4:e1000117.
58. Rolando M., Sanulli S., Rusniok C., Gomez-Valero L., Bertholet C., Sahr T., Margueron R., Buchrieser C. Legionella pneumophila effector RomA uniquely modifies host chromatin to repress gene expression and promote intracellular bacterial replication. Cell Host Microbe 2013, 13:395-405.
59. Li T., Lu Q., Wang G., Xu H., Huang H., Cai T., Kan B., Ge J., Shao F. SET-domain bacterial effectors target heterochromatin protein 1 to activate host rDNA transcription. EMBO Rep 2013, 14:733-740.